{"id":359689,"date":"2025-08-30T10:51:19","date_gmt":"2025-08-30T10:51:19","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-artivion\/"},"modified":"2025-08-30T10:51:19","modified_gmt":"2025-08-30T10:51:19","slug":"how-to-buy-artivion","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/","title":{"rendered":"How to buy Artivion, Inc. (AORT) shares &#8211; Investment in Artivion, Inc. (AORT) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-359689","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Artivion, Inc. (AORT) Shares - Investment in Artivion, Inc. (AORT) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Artivion, Inc. (AORT) Shares - Investment in Artivion, Inc. (AORT) Stock"},"description":"Learn how to buy Artivion, Inc. (AORT) shares with our complete investment guide. Discover current stock performance, risk analysis, and step-by-step trading strategies for 2025.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Artivion, Inc. (AORT) shares with our complete investment guide. Discover current stock performance, risk analysis, and step-by-step trading strategies for 2025."},"intro":"Thinking about investing in a medical device company that's making waves in cardiac surgery? Artivion, Inc. (AORT) combines cutting-edge technology with strong growth potential\u2014perfect for investors looking beyond traditional healthcare stocks. With innovative aortic solutions and impressive recent earnings, this company offers a unique opportunity to tap into the expanding medical device market.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in a medical device company that's making waves in cardiac surgery? Artivion, Inc. (AORT) combines cutting-edge technology with strong growth potential\u2014perfect for investors looking beyond traditional healthcare stocks. With innovative aortic solutions and impressive recent earnings, this company offers a unique opportunity to tap into the expanding medical device market."},"body_html":"<h2>\ud83d\udcc8 Artivion Stock: Current Price and Market Position<\/h2> <p>As of August 30, 2025, Artivion, Inc. (AORT) trades at <strong>$43.80<\/strong> on the NYSE. Mark your calendar: <strong>November 6, 2025<\/strong> is absolutely critical\u2014that's when Artivion releases its next quarterly earnings. Historically, these reports have moved prices dramatically.<\/p> <h3>How Earnings Reports Impact AORT Stock<\/h3> <p>The August 7, 2025 earnings release was a game-changer. The stock surged from approximately <strong>$32 to over $41<\/strong> in early August following the outstanding Q2 results. This represents a massive <strong>25%+ single-day gain<\/strong> that caught many investors by surprise.<\/p> <p>Looking at recent earnings patterns:<\/p> <ul> <li><strong>August 7, 2025<\/strong>: Q2 earnings beat expectations with $0.24 EPS vs. $0.11 estimates \u2192 <strong>25% price surge<\/strong><\/li> <li><strong>May 2025<\/strong>: Previous earnings showed steady growth but less dramatic movement<\/li> <li><strong>February 2025<\/strong>: Solid performance but overshadowed by broader market conditions<\/li> <\/ul> <p>The pattern is clear: when Artivion beats earnings expectations significantly, the stock reacts with explosive upward momentum. This makes the November 6th date particularly important for both current shareholders and potential buyers.<\/p> <h3>6-Month Price Journey (March-August 2025)<\/h3> <p>Artivion shares have delivered an <strong>impressive 36%+ return<\/strong> over the past six months:<\/p> <p><strong>March 2025<\/strong>: Around $32 (post-winter consolidation)<br\/> <strong>April 2025<\/strong>: Gradual climb to $35 (growing investor confidence)<br\/> <strong>May 2025<\/strong>: Reached $38 (strong quarterly results anticipation)<br\/> <strong>June 2025<\/strong>: Temporary pullback to $34 (market volatility)<br\/> <strong>July 2025<\/strong>: Steady recovery to $37 (technical support holding)<br\/> <strong>August 2025<\/strong>: Explosive growth to $43.80 (Q2 earnings catalyst)<\/p> <p>This upward trajectory reflects several key factors:<\/p> <ul> <li>Strong demand for cardiac medical devices<\/li> <li>Successful recovery from previous cybersecurity challenges<\/li> <li>Improved healthcare spending trends<\/li> <li>Strategic partnerships expanding market reach<\/li> <\/ul> [cta_green text=\"Start trading\"]<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst projections and company performance, here's what to expect:<\/p> <p><strong>2025 Year-End<\/strong>: $45-48 range (continued momentum from strong earnings)<br\/> <strong>2026 Projection<\/strong>: $52-58 (market expansion and new product launches)<br\/> <strong>2028 Outlook<\/strong>: $65-75 (established market leadership position)<br\/> <strong>2030 Vision<\/strong>: $85-100+ (global healthcare infrastructure growth)<\/p> <p><strong>Verdict<\/strong>: STRONG BUY for long-term investors. The combination of innovative technology, growing market demand, and strong financial performance creates an attractive investment opportunity.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>Regulatory hurdles<\/strong>: FDA approval processes can delay product launches<\/li> <li><strong>High volatility<\/strong>: 8% weekly swings require strong risk management<\/li> <li><strong>Profitability challenges<\/strong>: Negative EBIT margins despite revenue growth<\/li> <li><strong>Competition pressure<\/strong>: Larger medical device companies entering similar markets<\/li> <li><strong>Debt levels<\/strong>: Total debt-to-equity ratio of 1.23 requires monitoring<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>Earnings explosion<\/strong>: Q2 EPS of $0.24 beat estimates by 118%<\/li> <li><strong>Revenue growth<\/strong>: 15% year-over-year increase to $113 million<\/li> <li><strong>Strategic partnerships<\/strong>: $25 million funding deal with Endospan for NEXUS device<\/li> <li><strong>Industry trend<\/strong>: Cardiac device market growing at 7% annually<\/li> <li><strong>Technical momentum<\/strong>: Golden Star Signal occurred May 5, 2025<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start small<\/strong>: Begin with a position size you're comfortable with\u2014even 1-2 shares gets you started<\/li> <li><strong>Watch November 6th<\/strong>: Set alerts for the earnings release and be ready for potential volatility<\/li> <li><strong>Diversify wisely<\/strong>: Keep AORT as part of a balanced portfolio, not your entire strategy<\/li> <li><strong>Learn continuously<\/strong>: Follow medical device industry trends and regulatory developments<\/li> <\/ol> <p>Humorous trader wisdom: \"Trading AORT is like heart surgery\u2014precision matters more than speed. Nobody wants a 'triple bypass' on their portfolio!\"<\/p> <h2>\u2705 How to Buy Artivion, Inc. (AORT) Shares - Step by Step<\/h2> <table border=\"1\" cellpadding=\"5\" cellspacing=\"0\"> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NYSE-listed stocks and has reasonable fees<\/td><\/tr> <tr><td>2<\/td><td>Complete account verification<\/td><td>Most platforms require ID verification for security<\/td><\/tr> <tr><td>3<\/td><td>Deposit funds<\/td><td>Start with an amount you're comfortable risking<\/td><\/tr> <tr><td>4<\/td><td>Search for \"AORT\"<\/td><td>Use the ticker symbol, not just the company name<\/td><\/tr> <tr><td>5<\/td><td>Set your order type<\/td><td>Limit orders help control your entry price<\/td><\/tr> <tr><td>6<\/td><td>Review and confirm<\/td><td>Double-check share quantity and order details<\/td><\/tr> <tr><td>7<\/td><td>Monitor your position<\/td><td>Set price alerts for important levels<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>For those starting their investment journey, Pocket Option offers several advantages that make accessing stocks like Artivion more approachable:<\/p> <p><strong>Minimum deposit of just $5<\/strong>\u2014you can test strategies with minimal risk before committing larger amounts. This is particularly valuable when trading volatile stocks like AORT that can experience 8% weekly swings.<\/p> <p><strong>Rapid verification process<\/strong>\u2014typically completed within minutes using a single document. This means you can respond quickly to market opportunities without lengthy account setup delays.<\/p> <p><strong>Multiple withdrawal options<\/strong>\u2014over 100 methods including cryptocurrencies, e-wallets, and traditional banking options. This flexibility ensures you can access your profits in the way that works best for you.<\/p> <p>The platform's user-friendly interface makes it ideal for beginners who want to focus on learning market dynamics rather than navigating complex trading software.<\/p> <h2>\ud83c\udf0d Artivion in 2025: Cardiac Innovation Leader<\/h2> <p>Artivion stands as a specialized medical device company focused exclusively on cardiac and vascular surgery technologies. The company has carved out a unique niche in aortic disease treatment, collaborating with world-renowned surgeons to develop life-changing technologies.<\/p> <p>The company's product portfolio includes four main categories:<\/p> <ul> <li><strong>Aortic stent grafts<\/strong> for complex vascular repairs<\/li> <li><strong>On-X mechanical heart valves<\/strong> with reduced anticoagulation requirements<\/li> <li><strong>Surgical sealants<\/strong> like BioGlue for enhanced surgical outcomes<\/li> <li><strong>Implantable human tissues<\/strong> for cardiac reconstruction<\/li> <\/ul> <p>With a market capitalization of approximately $2.07 billion, Artivion competes against larger medical device firms by emphasizing clinical data, strong surgeon relationships, and execution in emerging markets.<\/p> <p><strong>Interesting Fact<\/strong>: In 2025, Artivion's On-X mechanical heart valve demonstrated such significant clinical benefits that it opened an estimated $100 million expansion opportunity in the United States alone\u2014all because of trial data showing reduced major bleeding risk for patients.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Artivion Stock: Current Price and Market Position<\/h2>\n<p>As of August 30, 2025, Artivion, Inc. (AORT) trades at <strong>$43.80<\/strong> on the NYSE. Mark your calendar: <strong>November 6, 2025<\/strong> is absolutely critical\u2014that&#8217;s when Artivion releases its next quarterly earnings. Historically, these reports have moved prices dramatically.<\/p>\n<h3>How Earnings Reports Impact AORT Stock<\/h3>\n<p>The August 7, 2025 earnings release was a game-changer. The stock surged from approximately <strong>$32 to over $41<\/strong> in early August following the outstanding Q2 results. This represents a massive <strong>25%+ single-day gain<\/strong> that caught many investors by surprise.<\/p>\n<p>Looking at recent earnings patterns:<\/p>\n<ul>\n<li><strong>August 7, 2025<\/strong>: Q2 earnings beat expectations with $0.24 EPS vs. $0.11 estimates \u2192 <strong>25% price surge<\/strong><\/li>\n<li><strong>May 2025<\/strong>: Previous earnings showed steady growth but less dramatic movement<\/li>\n<li><strong>February 2025<\/strong>: Solid performance but overshadowed by broader market conditions<\/li>\n<\/ul>\n<p>The pattern is clear: when Artivion beats earnings expectations significantly, the stock reacts with explosive upward momentum. This makes the November 6th date particularly important for both current shareholders and potential buyers.<\/p>\n<h3>6-Month Price Journey (March-August 2025)<\/h3>\n<p>Artivion shares have delivered an <strong>impressive 36%+ return<\/strong> over the past six months:<\/p>\n<p><strong>March 2025<\/strong>: Around $32 (post-winter consolidation)<br \/> <strong>April 2025<\/strong>: Gradual climb to $35 (growing investor confidence)<br \/> <strong>May 2025<\/strong>: Reached $38 (strong quarterly results anticipation)<br \/> <strong>June 2025<\/strong>: Temporary pullback to $34 (market volatility)<br \/> <strong>July 2025<\/strong>: Steady recovery to $37 (technical support holding)<br \/> <strong>August 2025<\/strong>: Explosive growth to $43.80 (Q2 earnings catalyst)<\/p>\n<p>This upward trajectory reflects several key factors:<\/p>\n<ul>\n<li>Strong demand for cardiac medical devices<\/li>\n<li>Successful recovery from previous cybersecurity challenges<\/li>\n<li>Improved healthcare spending trends<\/li>\n<li>Strategic partnerships expanding market reach<\/li>\n<\/ul>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst projections and company performance, here&#8217;s what to expect:<\/p>\n<p><strong>2025 Year-End<\/strong>: $45-48 range (continued momentum from strong earnings)<br \/> <strong>2026 Projection<\/strong>: $52-58 (market expansion and new product launches)<br \/> <strong>2028 Outlook<\/strong>: $65-75 (established market leadership position)<br \/> <strong>2030 Vision<\/strong>: $85-100+ (global healthcare infrastructure growth)<\/p>\n<p><strong>Verdict<\/strong>: STRONG BUY for long-term investors. The combination of innovative technology, growing market demand, and strong financial performance creates an attractive investment opportunity.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>Regulatory hurdles<\/strong>: FDA approval processes can delay product launches<\/li>\n<li><strong>High volatility<\/strong>: 8% weekly swings require strong risk management<\/li>\n<li><strong>Profitability challenges<\/strong>: Negative EBIT margins despite revenue growth<\/li>\n<li><strong>Competition pressure<\/strong>: Larger medical device companies entering similar markets<\/li>\n<li><strong>Debt levels<\/strong>: Total debt-to-equity ratio of 1.23 requires monitoring<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>Earnings explosion<\/strong>: Q2 EPS of $0.24 beat estimates by 118%<\/li>\n<li><strong>Revenue growth<\/strong>: 15% year-over-year increase to $113 million<\/li>\n<li><strong>Strategic partnerships<\/strong>: $25 million funding deal with Endospan for NEXUS device<\/li>\n<li><strong>Industry trend<\/strong>: Cardiac device market growing at 7% annually<\/li>\n<li><strong>Technical momentum<\/strong>: Golden Star Signal occurred May 5, 2025<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start small<\/strong>: Begin with a position size you&#8217;re comfortable with\u2014even 1-2 shares gets you started<\/li>\n<li><strong>Watch November 6th<\/strong>: Set alerts for the earnings release and be ready for potential volatility<\/li>\n<li><strong>Diversify wisely<\/strong>: Keep AORT as part of a balanced portfolio, not your entire strategy<\/li>\n<li><strong>Learn continuously<\/strong>: Follow medical device industry trends and regulatory developments<\/li>\n<\/ol>\n<p>Humorous trader wisdom: &#8220;Trading AORT is like heart surgery\u2014precision matters more than speed. Nobody wants a &#8216;triple bypass&#8217; on their portfolio!&#8221;<\/p>\n<h2>\u2705 How to Buy Artivion, Inc. (AORT) Shares &#8211; Step by Step<\/h2>\n<table border=\"1\" cellpadding=\"5\" cellspacing=\"0\">\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NYSE-listed stocks and has reasonable fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account verification<\/td>\n<td>Most platforms require ID verification for security<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Deposit funds<\/td>\n<td>Start with an amount you&#8217;re comfortable risking<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search for &#8220;AORT&#8221;<\/td>\n<td>Use the ticker symbol, not just the company name<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Set your order type<\/td>\n<td>Limit orders help control your entry price<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Review and confirm<\/td>\n<td>Double-check share quantity and order details<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Monitor your position<\/td>\n<td>Set price alerts for important levels<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>For those starting their investment journey, Pocket Option offers several advantages that make accessing stocks like Artivion more approachable:<\/p>\n<p><strong>Minimum deposit of just $5<\/strong>\u2014you can test strategies with minimal risk before committing larger amounts. This is particularly valuable when trading volatile stocks like AORT that can experience 8% weekly swings.<\/p>\n<p><strong>Rapid verification process<\/strong>\u2014typically completed within minutes using a single document. This means you can respond quickly to market opportunities without lengthy account setup delays.<\/p>\n<p><strong>Multiple withdrawal options<\/strong>\u2014over 100 methods including cryptocurrencies, e-wallets, and traditional banking options. This flexibility ensures you can access your profits in the way that works best for you.<\/p>\n<p>The platform&#8217;s user-friendly interface makes it ideal for beginners who want to focus on learning market dynamics rather than navigating complex trading software.<\/p>\n<h2>\ud83c\udf0d Artivion in 2025: Cardiac Innovation Leader<\/h2>\n<p>Artivion stands as a specialized medical device company focused exclusively on cardiac and vascular surgery technologies. The company has carved out a unique niche in aortic disease treatment, collaborating with world-renowned surgeons to develop life-changing technologies.<\/p>\n<p>The company&#8217;s product portfolio includes four main categories:<\/p>\n<ul>\n<li><strong>Aortic stent grafts<\/strong> for complex vascular repairs<\/li>\n<li><strong>On-X mechanical heart valves<\/strong> with reduced anticoagulation requirements<\/li>\n<li><strong>Surgical sealants<\/strong> like BioGlue for enhanced surgical outcomes<\/li>\n<li><strong>Implantable human tissues<\/strong> for cardiac reconstruction<\/li>\n<\/ul>\n<p>With a market capitalization of approximately $2.07 billion, Artivion competes against larger medical device firms by emphasizing clinical data, strong surgeon relationships, and execution in emerging markets.<\/p>\n<p><strong>Interesting Fact<\/strong>: In 2025, Artivion&#8217;s On-X mechanical heart valve demonstrated such significant clinical benefits that it opened an estimated $100 million expansion opportunity in the United States alone\u2014all because of trial data showing reduced major bleeding risk for patients.<\/p>\n"},"faq":[{"question":"What is Artivion's main business?","answer":"Artivion develops and manufactures specialized medical devices for cardiac and vascular surgery, particularly focusing on aortic disease treatments and mechanical heart valves."},{"question":"How often does Artivion report earnings?","answer":"The company reports quarterly earnings, with the next announcement scheduled for November 6, 2025 after market close."},{"question":"What was Artivion's most recent earnings performance?","answer":"Q2 2025 results showed outstanding performance with EPS of $0.24 (beating $0.11 estimates) and revenue growth of 15% year-over-year to $113 million."},{"question":"Does Artivion pay dividends?","answer":"Currently, Artivion does not pay dividends as the company reinvests profits into research, development, and market expansion activities."},{"question":"What makes Artivion different from other medical device companies?","answer":"Artivion's unique focus on aortic-centric technologies and collaboration with leading cardiac surgeons creates specialized expertise that larger competitors often lack, allowing them to innovate in niche areas of cardiac care."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is Artivion's main business?","answer":"Artivion develops and manufactures specialized medical devices for cardiac and vascular surgery, particularly focusing on aortic disease treatments and mechanical heart valves."},{"question":"How often does Artivion report earnings?","answer":"The company reports quarterly earnings, with the next announcement scheduled for November 6, 2025 after market close."},{"question":"What was Artivion's most recent earnings performance?","answer":"Q2 2025 results showed outstanding performance with EPS of $0.24 (beating $0.11 estimates) and revenue growth of 15% year-over-year to $113 million."},{"question":"Does Artivion pay dividends?","answer":"Currently, Artivion does not pay dividends as the company reinvests profits into research, development, and market expansion activities."},{"question":"What makes Artivion different from other medical device companies?","answer":"Artivion's unique focus on aortic-centric technologies and collaboration with leading cardiac surgeons creates specialized expertise that larger competitors often lack, allowing them to innovate in niche areas of cardiac care."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Artivion, Inc. (AORT) shares - Investment in Artivion, Inc. (AORT) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Artivion, Inc. (AORT) shares - Investment in Artivion, Inc. (AORT) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-30T10:51:19+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Artivion, Inc. (AORT) shares &#8211; Investment in Artivion, Inc. (AORT) stock\",\"datePublished\":\"2025-08-30T10:51:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/\",\"name\":\"How to buy Artivion, Inc. (AORT) shares - Investment in Artivion, Inc. (AORT) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"datePublished\":\"2025-08-30T10:51:19+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Artivion, Inc. (AORT) shares &#8211; Investment in Artivion, Inc. (AORT) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Artivion, Inc. (AORT) shares - Investment in Artivion, Inc. (AORT) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Artivion, Inc. (AORT) shares - Investment in Artivion, Inc. (AORT) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-30T10:51:19+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Artivion, Inc. (AORT) shares &#8211; Investment in Artivion, Inc. (AORT) stock","datePublished":"2025-08-30T10:51:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/","name":"How to buy Artivion, Inc. (AORT) shares - Investment in Artivion, Inc. (AORT) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","datePublished":"2025-08-30T10:51:19+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-artivion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Artivion, Inc. (AORT) shares &#8211; Investment in Artivion, Inc. (AORT) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":359767,"slug":"how-to-buy-artivion","post_title":"Comment acheter des actions Artivion, Inc. (AORT) - Investir dans les actions Artivion, Inc. (AORT)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-artivion\/"},"it_IT":{"locale":"it_IT","id":359764,"slug":"how-to-buy-artivion","post_title":"Come acquistare azioni Artivion, Inc. (AORT) - Investire in azioni Artivion, Inc. (AORT)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-artivion\/"},"pl_PL":{"locale":"pl_PL","id":359765,"slug":"how-to-buy-artivion","post_title":"Jak kupi\u0107 akcje Artivion, Inc. (AORT) - Inwestycja w akcje Artivion, Inc. (AORT)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-artivion\/"},"es_ES":{"locale":"es_ES","id":359766,"slug":"how-to-buy-artivion","post_title":"C\u00f3mo comprar acciones de Artivion, Inc. (AORT) - Inversi\u00f3n en acciones de Artivion, Inc. (AORT)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-artivion\/"},"th_TH":{"locale":"th_TH","id":359769,"slug":"how-to-buy-artivion","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Artivion, Inc. (AORT) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Artivion, Inc. (AORT)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-artivion\/"},"tr_TR":{"locale":"tr_TR","id":359768,"slug":"how-to-buy-artivion","post_title":"Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/"},"vt_VT":{"locale":"vt_VT","id":359763,"slug":"how-to-buy-artivion","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Artivion, Inc. (AORT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Artivion, Inc. (AORT)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-artivion\/"},"pt_AA":{"locale":"pt_AA","id":359762,"slug":"how-to-buy-artivion","post_title":"Como comprar a\u00e7\u00f5es da Artivion, Inc. (AORT) - Investimento em a\u00e7\u00f5es da Artivion, Inc. (AORT)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-artivion\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/359689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=359689"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/359689\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334036"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=359689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=359689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=359689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}